Recombinant influenza viruses with stabilized HA for replication in eggs
US11807872B2 · kind B2 · utility
10Cited by
110References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 27, 2020 |
| Grant date | Nov 7, 2023 |
| Priority date | — |
| Expiry date | Aug 27, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16151
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Modified influenza virus neuraminidases are described herein that improve viral replication, thus improving the yield of vaccine viruses. Expression of such modified neuraminidases by influenza virus may also stabilize co-expressed hemagglutinins so that the hemagglutinins do not undergo mutation or decrease the need for HA binding to cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.